Clinical Neuroendocrine Relationships in Normal and Disordered Prolactin Secretion

  • G. M. Besser
  • T. Yeo
  • G. Delitala
  • Ann Jones
  • W. A. Stubbs
  • J. A. H. Wass
  • M. O. Thorner
Part of the Published Nobel Symposia book series (NOFS, volume 42)

Abstract

Fortunately the establishment of the existence of prolactin in man coincided with the clarification the neurohumoral control of prolactin secretion in subhuman species in the decade around 1970 (see review by Thorner, 1977); this allowed the rapid extension of these studies into the clinical sphere. In general terms the mechanisms controlling secretion of prolactin appear similar in man and other mammals and this has allowed the successful exploitation of basic neuroendocrine advances to the development of drugs of great value for the clinical control of the common hyperprolact-inaemic states and these will be reviewed here.

Keywords

Adenoma Androgen Oestradiol Haloperidol Infertility 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bowers, C.Y., Friesen, H., Hwang, P., Guyda, H., and Folkers, K. Biochem. Biophys. Res. Commun. 45, 1033–1041, (1971).PubMedCrossRefGoogle Scholar
  2. Berch, T., Nillius, S.J. and Wide, L. Brit. Med. J., 1, 875–880, (1978).CrossRefGoogle Scholar
  3. Besser, G.M., Parkes, L., Edwards, C.R.W., Forsyth, I.A. and McNeilly, A.S. Brit. Med. J. 3, 669–672, (1972).PubMedCrossRefGoogle Scholar
  4. Cornblum, B., Webster, B.R., Mortimer, C.B., and Ezrin, C. Clin. Res. 33, 614A, (1975).Google Scholar
  5. Corrodi, H., Fuxe, K., Hokfelt, T., Lidbrink, P., and Ungerstedt, U. J. Pharmacol. 25, 409–412, (1973).CrossRefGoogle Scholar
  6. Davies, C., Jacobs, J., Lloyd, H.M., and Meares, J.D. J. Endocrinol, 61, 411–417, (1974).PubMedCrossRefGoogle Scholar
  7. Del Pozo, E., Wyss, H., Lancranyan, I., Obolensky, W., and Varga, L. In “Ovulation in the Human” (P.G. Crosignani and D.R. Mishell, eds), Serono Symp. No. 8, pp. 297–299. Academic Press, New York, (1976).Google Scholar
  8. Dupont, A., and Redding, T.W. Program 57th Meet. Endocr. Soc., New York, Abstract No. 85, (1975).Google Scholar
  9. Enjalbert, A., Moos, F., Carbonell, L., Priam, M. and Kordon, C. Neuroendocrinology, 24, 147–161, (1977).PubMedCrossRefGoogle Scholar
  10. Fluckiger, E., and Wagner, H. Experientia 24, 1130–1131, (1968).PubMedCrossRefGoogle Scholar
  11. Frohman, L.A., and Szabo, M. Program, 57th Annu. Meet. Endocr. Soc., New York Abstract 86, (1975).Google Scholar
  12. Fuxe, K., Corrodi, H., Hodfelt, T., Lidbrink, P., and Ungerstedt, U. Med. Biol. 52, 121–132, (1974).PubMedGoogle Scholar
  13. Gallo, R.V., Rabii, J., and Moberg, G.P. Endocrinology 97, 1096–1105, (1975).PubMedCrossRefGoogle Scholar
  14. Glass, M.R., Shaw, R.W., Butt, W.R., Logan Edwards, R., and London, D.R. Brit. Med. J. 3, 274–275, (1975).PubMedCrossRefGoogle Scholar
  15. Griffiths, R.W., Turkalj, I., and Braun, P. Brit. J. Clin. Pharmac. 5, 227–231, (1978).Google Scholar
  16. Hardy, J. In “Diagnosis and Treatment of Pituitary Tumours” (P.O. Kohler and G.T. Ross, eds.), Int. Congr. Ser. No. 303. pp. 179–194. Excerpta Med. Found., Amsterdam, (1973).Google Scholar
  17. Jacobs, L.S., Snyder, P.J., Wilber, J.F., Utiger, R.D. and Daughaday, W.H. J. Clin. Endocr. Metab. 33, 996–998, (1971).PubMedCrossRefGoogle Scholar
  18. Kamberi, I.A., Mical, R.S., and Porter, J.C. Endocrinology 88, 1012–1020, (1971).PubMedCrossRefGoogle Scholar
  19. Kato, Y., Nakai, Y., Imura H., Chihara, K., and Ohgo, S. J. Clin. Endocr. Metab. 38, 695–697, (1974).CrossRefGoogle Scholar
  20. Kordon, C., Blake, C.A., Terkel, J., and Sawyer, C.H. Neuroendocrinology 13, 213–223, (1973–1974).CrossRefGoogle Scholar
  21. Labella, F.S., Dular, R., and Vivian, S.R. Endocrinology International Congress, 4th Washington D.C. Excerpta Med. Int. Congr. Ser. 256, 141 Abstr. 354, (1972).Google Scholar
  22. Lloyd, H.M., Meares, J.D., and Jacobi, J. Nature (London) 255, 497–498, (1975).CrossRefGoogle Scholar
  23. Lu, K.H., and Meites, J. Proc. Soc. Exp. Biol. Med. 132, 480–483, (1971).Google Scholar
  24. MacLeod, R.M. Int. Semin. Reprod. Physiol. Sexual Endocrinol., 6th Prog. Reprod. Biol. 2, 54–68, (1977).Google Scholar
  25. MacLeod, R.M., and Lehmeyer, J.E. Cancer Res. 33, 849–855, (1973).PubMedGoogle Scholar
  26. McNatty, K.P., Sawers, R.S., and McNeilly, A.S. Nature (London) 250, 653–655, (1974).CrossRefGoogle Scholar
  27. Mendelson, W.B., Jacobs, L.S., Reichman, J.D., Othmer, E., Cryer, P.E., Trivedi, B., and Daughaday, W.H. J. Clin. Invest. 56, 690–697, (1975).CrossRefGoogle Scholar
  28. Mortimer, C.H., Besser, G.M., McNeilly, A.S., Marshall, J.C., Harsoulis, P., Tunbridge, W.M.G., Gomez-Pan, A., and Hall, R. Brit. Med. J. 4, 73–77, (1973).PubMedCrossRefGoogle Scholar
  29. Mortimer, C.H., Besser, G.M., Goldie, D.J., Hook, J., and McNeilly, A.S. Clin. Endocrinol. (Oxford) 3, 97–103, (1974).CrossRefGoogle Scholar
  30. Noel, G.L., Dimond, R.C. Wartofsky, L., Earll, J.M., and Frantz, A.G. J. Clin. Endocr. Metab. 39, 6–17, (1974).PubMedCrossRefGoogle Scholar
  31. Quadri, S.K., and Meites, J. Proc. Soc. Exp. Biol. Med. 142, 837–841, (1973).PubMedGoogle Scholar
  32. Seppala, M., Hirvonen, E., and Ranta, T. Lancet 1, 229–230, (1976).PubMedCrossRefGoogle Scholar
  33. Thorner, M.O. In “Clinical Neuroendocrinology”. Eds. Martini, L. and Besser, G.M. Academic Press, New York, p.319–361, (1977).Google Scholar
  34. Thorner, M.O. Lancet 1, 662–665, (1975).PubMedCrossRefGoogle Scholar
  35. Thorner, M.O., Besser, G.M., Hagen, C., and McNeilly, A.S. Brit. Med. J. 2 419–422, (1974).PubMedCrossRefGoogle Scholar
  36. Thorner, M.O., Besser, G.M., Jones, A., Dacie, J. and Jones, A.E. Brit. Med. J. 4, 694–697, (1975).PubMedCrossRefGoogle Scholar
  37. Thorner, M.O., Edwards, C.R.W., Hanker, J.P., Abraham, G. and Besser G.M. In “The Testes in Normal and Infertile Men” (P. Troen and H. Nankin, eds.) pp. 351–366, Raven Press, New York, (1977).Google Scholar
  38. Thorner, M.O., Ryan, S.M., Wass, J.A.H., Jones, Ann, Bouloux, P., Shaw, J.E.H., Williams, Sally, Besser, G.M. The effect of the dopamine agonist, lergotrile mesylate on circulating anterior pituitary hormones in man. J. Clin. Endocr. Metab. In Press (1978).Google Scholar
  39. Turkington, R.W. and MacIndoe, J.H. J. Clin. Invest. 51: 323 (abstr), (1972).Google Scholar
  40. Valverdi R. C., Chieffo, V., and Reichlin, S. Endocrinology 91, 982–993 (1972).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • G. M. Besser
    • 1
  • T. Yeo
    • 1
  • G. Delitala
    • 1
  • Ann Jones
    • 1
  • W. A. Stubbs
    • 1
  • J. A. H. Wass
    • 1
  • M. O. Thorner
    • 1
  1. 1.Department of EndocrinologySt. Bartholomew’s HospitalLondonEngland

Personalised recommendations